Skip to main content

Advertisement

Table 4 Clinico-pathological data of patients with unavailable chemotherapy-related toxicity data

From: D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy

  Patient data (n = 40)
Clinical data  
Median age in years (range) 52.5 (23 to 85)
Sex (M:F) 28:12 (70%:30%)
Tumor location (endoscopic)  
Gastro-esophageal region 11
Pyloric-antrum 22
Body 3
Fundus 3
Whole stomach, linitis plastica-type 1
Surgeries  
Total gastrectomy 10
Proximal gastrectomy 7
Subtotal gastrectomy 13
Inoperable/palliative surgeries 10
Median blood loss in ml (range) 500 (100 to 1000)
Median units of blood transfused (range) 0 (0 to 1)
Morbidity ratea 16.6% (5)
Mortality rate 0% (0)
Median duration of hospital stay in days (range) 9 (3 to 35)
Histopathological data of patients who underwent radical resections Patient data (n = 30)
Final pathology  
Well-differentiated adenocarcinoma 1
Moderately-differentiated adenocarcinoma 8
Poorly differentiated adenocarcinoma 11
Signet ring cell adenocarcinoma 7
Microscopic foci of adenocarcinoma 1
No residual tumor 2
T-stage  
T1 2
T2 9
T3 12
T4 5
Perineural invasion present 6 (20%)
Lymphovascular invasion present 13 (43%)
Median number of lymph nodes harvested (range) 15 (1 to 36)
Median number of positive nodes (range) 1 (0 to 14)
Positive microscopic resection margin 4 (13%)
  1. aComplications included duodenal stump leaks (2 patients), delayed gastric emptying grade B (1 patient), pneumonia (1 patient) and intra-abdominal collection (1 patient).